Dallas, Texas – Tenet Healthcare Corporation reported strong financial results in the second quarter of 2024 during their recent earnings conference call. With a focus on sustainable growth, the company exceeded expectations with net operating revenues reaching $5.1 billion. The consolidated adjusted EBITDA of $945 million represented a 12% increase from the same quarter in 2023.

During the call, senior management shared insights into the company’s performance. Dr. Saum Sutaria, Chairman and CEO, highlighted the robust second-quarter results driven by fundamental growth and disciplined operations. The company saw strong performance in its USPI segment, with $447 million in adjusted EBITDA, a 21% growth over the previous year.

The company also expanded its reach by adding 11 new centers in the quarter, with a focus on partnerships and acquisitions to support growth in their markets. In the Hospital segment, adjusted EBITDA reached $498 million. With a focus on strategic investments to support growth, Tenet is set to open a new hospital in Westover Hills, near San Antonio, to cater to a growing market.

Looking ahead, Tenet raised its full-year 2024 adjusted EBITDA guidance to a range of $3.825 billion to $3.975 billion, representing an increase of $300 million from previous guidance. The company remains committed to driving value for shareholders through strategic capital deployment, including investments in ambulatory surgical centers and technology enhancements for clinical and administrative efficiency.

The company’s diversified portfolio and focus on operational improvements position Tenet Healthcare for continued success in the future. As the healthcare industry evolves, Tenet remains focused on delivering high-quality care and driving sustainable growth across its business units.